Racial and ethnic differences in circulating N-terminal pro-brain-type natriuretic peptide (NT-proBNP) in US adults
© 2023 The Authors. Published by Elsevier B.V..
Background: The presence and interpretation of racial and ethnic differences in circulating N-terminal pro-brain-type natriuretic peptide (NT-proBNP), a diagnostic biomarker for heart failure, are controversial.
Objective: To examine racial and ethnic differences in NT-proBNP levels among the general US adult population.
Methods: We performed a cross-sectional analysis of data from the 1999-2004 National Health and Nutrition Examination Survey (NHANES). We included 4717 non-Hispanic White, 1675 non-Hispanic Black, and 2148 Mexican American adults aged 20 years or older without a history of cardiovascular disease. We examined the associations of race and ethnicity with NT-proBNP using linear and logistic regression models in the overall population and in a younger, 'healthy' subsample.
Results: The mean age was 45 years. Median NT-proBNP levels were significantly lower among Black (29.3 pg/mL) and Mexican American adults (28.3.4 pg/mL) compared to White adults (49.1pg/mL, P-values<0.001). After adjusting for sociodemographic factors and cardiovascular risk factors, NT-proBNP was 34.4% lower (95%CI -39.2 to -29.3%) in Black adults and 22.8% lower (95%CI -29.4 to -15.5) in Mexican American adults compared to White adults. Our findings were consistent in a young, healthy subsample, suggesting non-cardiometabolic determinants of these differences.
Conclusions: NT-proBNP levels are significantly lower among Black and Mexican American adults compared with White adults, independent of cardiometabolic risk. Although race/ethnicity is a poor proxy for genetic differences, our findings may have clinical implications for the management of HF. However, studies in diverse populations are needed to characterize the biological basis of NT-proBNP variation.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:15 |
---|---|
Enthalten in: |
American journal of preventive cardiology - 15(2023) vom: 22. Sept., Seite 100526 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Commodore-Mensah, Yvonne [VerfasserIn] |
---|
Links: |
---|
Themen: |
Biomarkers |
---|
Anmerkungen: |
Date Revised 11.08.2023 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
---|
doi: |
10.1016/j.ajpc.2023.100526 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM360600727 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM360600727 | ||
003 | DE-627 | ||
005 | 20231226083344.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.ajpc.2023.100526 |2 doi | |
028 | 5 | 2 | |a pubmed24n1201.xml |
035 | |a (DE-627)NLM360600727 | ||
035 | |a (NLM)37560479 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Commodore-Mensah, Yvonne |e verfasserin |4 aut | |
245 | 1 | 0 | |a Racial and ethnic differences in circulating N-terminal pro-brain-type natriuretic peptide (NT-proBNP) in US adults |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 11.08.2023 | ||
500 | |a published: Electronic-eCollection | ||
500 | |a Citation Status PubMed-not-MEDLINE | ||
520 | |a © 2023 The Authors. Published by Elsevier B.V. | ||
520 | |a Background: The presence and interpretation of racial and ethnic differences in circulating N-terminal pro-brain-type natriuretic peptide (NT-proBNP), a diagnostic biomarker for heart failure, are controversial | ||
520 | |a Objective: To examine racial and ethnic differences in NT-proBNP levels among the general US adult population | ||
520 | |a Methods: We performed a cross-sectional analysis of data from the 1999-2004 National Health and Nutrition Examination Survey (NHANES). We included 4717 non-Hispanic White, 1675 non-Hispanic Black, and 2148 Mexican American adults aged 20 years or older without a history of cardiovascular disease. We examined the associations of race and ethnicity with NT-proBNP using linear and logistic regression models in the overall population and in a younger, 'healthy' subsample | ||
520 | |a Results: The mean age was 45 years. Median NT-proBNP levels were significantly lower among Black (29.3 pg/mL) and Mexican American adults (28.3.4 pg/mL) compared to White adults (49.1pg/mL, P-values<0.001). After adjusting for sociodemographic factors and cardiovascular risk factors, NT-proBNP was 34.4% lower (95%CI -39.2 to -29.3%) in Black adults and 22.8% lower (95%CI -29.4 to -15.5) in Mexican American adults compared to White adults. Our findings were consistent in a young, healthy subsample, suggesting non-cardiometabolic determinants of these differences | ||
520 | |a Conclusions: NT-proBNP levels are significantly lower among Black and Mexican American adults compared with White adults, independent of cardiometabolic risk. Although race/ethnicity is a poor proxy for genetic differences, our findings may have clinical implications for the management of HF. However, studies in diverse populations are needed to characterize the biological basis of NT-proBNP variation | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Biomarkers | |
650 | 4 | |a Cardiovascular disease | |
650 | 4 | |a Epidemiology | |
650 | 4 | |a Ethnicity | |
650 | 4 | |a Race | |
700 | 1 | |a Wang, Dan |e verfasserin |4 aut | |
700 | 1 | |a Jeon, Yein |e verfasserin |4 aut | |
700 | 1 | |a Foti, Kathryn |e verfasserin |4 aut | |
700 | 1 | |a McEvoy, John William |e verfasserin |4 aut | |
700 | 1 | |a Coresh, Josef |e verfasserin |4 aut | |
700 | 1 | |a Tang, Olive |e verfasserin |4 aut | |
700 | 1 | |a Echouffo-Tcheugui, Justin B |e verfasserin |4 aut | |
700 | 1 | |a Christenson, Robert |e verfasserin |4 aut | |
700 | 1 | |a Ndumele, Chiadi E |e verfasserin |4 aut | |
700 | 1 | |a Selvin, Elizabeth |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t American journal of preventive cardiology |d 2020 |g 15(2023) vom: 22. Sept., Seite 100526 |w (DE-627)NLM314087893 |x 2666-6677 |7 nnns |
773 | 1 | 8 | |g volume:15 |g year:2023 |g day:22 |g month:09 |g pages:100526 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.ajpc.2023.100526 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 15 |j 2023 |b 22 |c 09 |h 100526 |